Skip to content
Fast Company1 min read

A new weight loss pill is here and it could...

A new GLP-1 pill is about to hit the market. On Wednesday, Eli Lilly announced its new GLP-1 pill, Foundayo, was approved by the Food and Drug Administration (FDA) for use in adults with obesity or weight-related health problems. The company says that drug trials saw patients taking Foundayo losing an average of 27.3 pounds (12.4%) compared to 2.2 pounds (0.9%) with a placebo. It said the drug will be available via LillyDirect, noting that it will begin accepting prescriptions immediately. It ex
Read original on fastcompany.com
0
0

Comment

Sign in to join the discussion.

Loading comments…

Related

r/startups1 min

Linear just announced "Issue Tracking is...

So we've been obsessing over "the moat" at my startup lately. It's the classic question: what actually protects us long-term? Nothing tunes the senses on this like watching somene else's moat disappear. In our weekly eng meeting, we were figuring out how to handle customer bug reports post-launch. One idea was routing them straight to Linear for triage. Normal stuff. We tabled it. More important stuff to do. Here's the thing though, my co-founder has basically stopped using Linear. We have a coo

reddit.com
19
9
Stratechery

Spring Break

Stratechery is on a bit of a disjointed Spring Break, as my usual week off will be spread out: I will return to my usual posting schedule on Tuesday, March 31. All other Stratechery Plus content, including my podcasts, will stay on schedule.

stratechery.com
0
0

Get the 10 best reads every Sunday

Curated by AI, voted by readers. Free forever.

Liked this? Start your own feed.

0
0